Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

4.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

2.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
Metastasis02:30

Metastasis

5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PRDM Proteins Orchestrate Colorectal Cancer Tumorigenesis.

International journal of molecular sciences·2026
Same author

PRDM players in central nervous system cancers: State of the art and future perspectives.

Critical reviews in oncology/hematology·2026
Same author

Gliosarcoma: A Reappraisal of Neuroradiological, Surgical, Morphological, and Radiotherapeutic Characteristics of a Cohort From South Italy Single-Center.

Analytical cellular pathology (Amsterdam)·2026
Same author

Epigenetic crosstalk between uric acid and vascular health: a role for extracellular vesicles.

Clinical epigenetics·2025
Same author

Beyond Anthropometry: The Clinical Role of Epigenetics in Prenatal Programming of Obesity.

American journal of preventive medicine·2025
Same author

siRNA-based therapeutic candidate targeting PRDM2 for inhibition of lung cancer progression.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

Related Experiment Video

Updated: May 4, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K

Involvement of Mediator complex in malignancy.

Concetta Schiano1, Amelia Casamassimi2, Monica Rienzo2

  • 1Institute of Diagnostic and Nuclear Development (SDN), IRCCS, Via E. Gianturco 113, 80143 Naples, Italy.

Biochimica Et Biophysica Acta
|December 18, 2013
PubMed
Summary

The Mediator complex (MED) is crucial for cell survival. Aberrant MED subunits are linked to cancer, offering potential as diagnostic markers and therapeutic targets for novel anti-cancer treatments.

Keywords:
BiomarkersCancerMediator complexTranscriptionTumorigenesis

More Related Videos

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

5.3K
Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

8.0K

Related Experiment Videos

Last Updated: May 4, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

5.3K
Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

8.0K

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The Mediator complex (MED) is an essential multiprotein complex regulating gene transcription in eukaryotes.
  • RNA polymerase II, general transcription factors, and chromatin regulators interact with MED subunits.
  • Transcriptional machinery dysfunction is implicated in cell proliferation, development, differentiation, and cancer.

Purpose of the Study:

  • To investigate the correlation between Mediator complex subunits and carcinogenesis.
  • To highlight the known and emerging roles of MED subunits in human cancers.
  • To explore the potential of MED subunits as diagnostic/prognostic markers and therapeutic targets in oncology.

Main Methods:

  • Review of existing literature on MED subunit mutations and expression alterations in human cancers.
  • Analysis of documented roles of specific MED subunits (MED1, MED28, MED12, CDK8, Cyclin C) in cancer.
  • Identification of emerging research on other MED subunits associated with malignancy.

Main Results:

  • Numerous MED subunits exhibit mutations or altered expression in human cancers.
  • Specific subunits like MED1, MED28, MED12, CDK8, and Cyclin C have well-established roles in cancer.
  • Emerging evidence suggests other MED subunits are also involved in malignancy.

Conclusions:

  • Understanding the Mediator complex's role in cancer is crucial for advancing oncology.
  • MED subunits show promise as novel diagnostic and prognostic tumor markers.
  • MED subunits represent potential targets for developing new molecular-targeted anti-cancer therapies.